Showing results (61-70 of 106) with videos related to
Sort By:
Pageof 11
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 8, 2024
C-Reactive Protein and Brain Natriuretic Peptides HarmonizationSara Pasqualetti, Michele Mussap, Elena Monteverde, et al.Journal of the American Society of Nephrology : JASN|June 7, 2005
Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetesMichele Dalla Vestra, Michele Mussap, Pietro Gallina, et al.Frontiers in Molecular Biosciences|July 2, 2021
Urine NMR Metabolomics Profile of Preterm Infants With Necrotizing Enterocolitis Over the First Two Months of Life: A Pilot Longitudinal Case-Control StudyJean-Charles Picaud, Anna De Magistris, Michele Mussap, et al.Frontiers in Molecular Biosciences|September 26, 2022
Metabolomics in OtorhinolaryngologyAntonio Noto, Cristina Piras, Luigi Atzori, et al.Metabolites|February 25, 2022
Alterations of the Intestinal Permeability are Reflected by Changes in the Urine Metabolome of Young Autistic Children: Preliminary ResultsCristina Piras, Michele Mussap, Antonio Noto, et al.Clinical Biochemistry|June 2, 2011
The ImmunoCAP ISAC molecular allergology approach in adult multi-sensitized Italian patients with respiratory symptomsGiovanni Melioli, Floriano Bonifazi, Sergio Bonini, et al.International Journal of Molecular Sciences|July 31, 2015
Prognostic Value of Preoperative Serum Levels of Periostin (PN) in Early Breast Cancer (BCa)Pier Vitale Nuzzo, Alessandra Rubagotti, Francesca Argellati, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|August 18, 2015
(1)H NMR-based urine metabolic profile of IUGR, LGA, and AGA newborns in the first week of lifeFlaminia Cesare Marincola, Angelica Dessì, Maria Grazia Pattumelli, et al.Thyroid Research|July 2, 2009
Long-term outcome of low-activity radioiodine administration preceded by adjuvant recombinant human TSH pretreatment in elderly subjects with multinodular goiterMassimo Giusti, Mauro Caputo, Iolanda Calamia, et al.Hormones (Athens, Greece)|December 7, 2007
Recombinant human thyroid stimulating hormone does not acutely change serum osteoprotegerin and soluble receptor activator of nuclear factor-kappaBeta ligand in patients under evaluation for differentiated thyroid carcinomaMassimo Giusti, Francesca Cecoli, Carla Ghiara, et al.Pageof 11